Systemic acylcarnitine levels are affected in response to multiple injuries and hemorrhagic shock - an analysis of lipidomic changes in a standardized porcine model.


Journal

The journal of trauma and acute care surgery
ISSN: 2163-0763
Titre abrégé: J Trauma Acute Care Surg
Pays: United States
ID NLM: 101570622

Informations de publication

Date de publication:
29 Mar 2024
Historique:
medline: 1 4 2024
pubmed: 1 4 2024
entrez: 1 4 2024
Statut: aheadofprint

Résumé

Along with recent advances in analytical technologies, TCA-cycle intermediates are increasingly identified as promising makers for cellular ischemia and mitochondrial dysfunction during hemorrhagic shock (HS). For traumatized patients, the knowledge of the role of lipid oxidation substrates is sparse. In this study, we aimed to analyze the dynamics of systemic acylcarnitine (AcCa) release in a standardized polytrauma model with HS. 52 male pigs (50 ± 5 kg) were randomized into two groups: Group IF (isolated fracture) was subject to a standardized femur shaft fracture. Group PT (polytrauma) was subject to a femur fracture, followed by blunt chest trauma, liver laceration and a pressure controlled hemorrhagic shock for 60 min. Resuscitation was performed with crystalloids. Fractures were stabilized by intramedullary nailing. Venous samples were collected at 6 timepoints (baseline, trauma, resuscitation, 2 h, 4 h and 6 h). Lipidomic analysis was performed via liquid chromatography coupled mass spectrometry. Measurements were collated with clinical markers and near-infrared spectrometry measurements (NIRS) of tissue perfusion. Longitudinal analyses were performed with linear mixed models and spearman's correlations were calculated. A p-value of 0.05 was defined as threshold for statistical significance. From a total of 303 distinct lipids, we identified two species of long-chain AcCas. Both showed a highly significant (p < 0.001) two-fold increase after HS in Group PT that promptly normalized after resuscitation. This increase was associated with a significant decrease of the base excess (p = 0.005) but recovery after resuscitation was faster. For both AcCas, there were significant correlations with decreased muscle tissue oxygen delivery (p = 0.008, p = 0.003) and significant time-lagged correlations with the increase of creatine kinase (p < 0.001, p < 0.001). Our results point to plasma AcCas as a possible indicator for mitochondrial dysfunction and cellular ischemia in HS. The more rapid normalization after resuscitation in comparison to acid base changes may warrant further investigation. Experimental Animal Model. N/A.

Identifiants

pubmed: 38556639
doi: 10.1097/TA.0000000000004328
pii: 01586154-990000000-00684
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Surgery of Trauma.

Déclaration de conflit d'intérêts

Conflict of Interest: Authors declare that they have no competing interests. JTACS disclosure forms have been supplied and are provided in the supplemental digital content (http://links.lww.com/TA/D692).

Auteurs

Yohei Kumabe (Y)

Harald-Tscherne Laboratory for Orthopaedic and Trauma Research, University of Zurich; Zurich, Switzerland.

Miriam Weisskopf (M)

Center for Preclinical Development, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.

Nikola Cesarovic (N)

Department of Health Sciences and Technology, Swiss Federal Institute of Technology, Zurich, Switzerland.

Andreas J Hülsmeier (AJ)

Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Sonja Märsmann (S)

Harald-Tscherne Laboratory for Orthopaedic and Trauma Research, University of Zurich; Zurich, Switzerland.

Christian Hierholzer (C)

Harald-Tscherne Laboratory for Orthopaedic and Trauma Research, University of Zurich; Zurich, Switzerland.

Frank Hildebrand (F)

Department of Orthopaedic Trauma and Reconstructive Surgery, University Hospital RWTH, Aachen, Germany.

Thorsten Hornemann (T)

Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Classifications MeSH